OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.26 USD
+0.04 (3.28%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.26 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -188.86 | -328.41 | -30.14 | 30.59 | -314.93 |
Depreciation/Amortization & Depletion | 106.52 | 109.82 | 79.50 | 86.21 | 94.80 |
Net Change from Assets/Liabilities | 21.80 | 42.65 | -20.48 | -97.61 | -68.81 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 32.35 | 80.75 | 9.46 | 20.29 | 116.41 |
Net Cash From Operating Activities | -28.20 | -95.19 | 38.34 | 39.48 | -172.52 |
Property & Equipment | -13.56 | -22.63 | 33.87 | -33.44 | -12.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1.76 | -4.00 | 0.00 | 0.00 |
Investments | -4.64 | 115.42 | 6.08 | 15.11 | -1.20 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -18.20 | 91.04 | 35.95 | -18.33 | -13.27 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.27 | -0.77 | 1.08 | 0.76 | 76.06 |
Issuance (Repayment) of Debt | -3.00 | 0.00 | 0.00 | 0.00 | 171.49 |
Increase (Decrease) Short-Term Debt | -8.03 | 23.75 | -11.24 | -35.83 | -64.54 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.19 | 0.00 | -7.76 |
Net Cash from Financing Activities | -11.30 | 22.97 | -10.35 | -35.08 | 175.25 |
Effect of Exchange Rate Changes | 0.39 | -0.34 | -1.44 | 0.69 | -0.48 |
Net Change In Cash & Equivalents | -57.31 | 18.48 | 62.50 | -13.24 | -11.02 |
Cash at Beginning of Period | 153.19 | 134.71 | 72.21 | 85.45 | 96.47 |
Cash at End of Period | 95.88 | 153.19 | 134.71 | 72.21 | 85.45 |
Diluted Net EPS | -0.25 | -0.46 | -0.05 | 0.05 | -0.53 |
Fiscal Year End for OPKO Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -188.86 | -122.38 | -37.91 | -18.27 |
Depreciation/Amortization & Depletion | NA | 106.52 | 80.22 | 53.59 | 26.74 |
Net Change from Assets/Liabilities | NA | 21.80 | 19.22 | -55.74 | -29.51 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 32.35 | 33.04 | 17.05 | -1.62 |
Net Cash From Operating Activities | NA | -28.20 | 10.10 | -23.01 | -22.65 |
Property & Equipment | NA | -13.56 | -12.14 | -8.21 | -2.72 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -4.64 | -4.64 | -5.00 | -5.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -18.20 | -16.78 | -13.21 | -7.72 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -0.27 | -0.27 | -0.30 | 0.00 |
Issuance (Repayment) of Debt | NA | -3.00 | -3.00 | -3.00 | -3.00 |
Increase (Decrease) Short-Term Debt | NA | -8.03 | -4.28 | -6.36 | -10.12 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -11.30 | -7.55 | -9.66 | -13.12 |
Effect of Exchange Rate Changes | NA | 0.39 | -0.34 | 0.79 | 1.12 |
Net Change In Cash & Equivalents | NA | -57.31 | -14.57 | -45.08 | -42.36 |
Cash at Beginning of Period | NA | 153.19 | 153.19 | 153.19 | 153.19 |
Cash at End of Period | NA | 95.88 | 138.62 | 108.11 | 110.83 |
Diluted Net EPS | NA | -0.09 | -0.11 | -0.03 | -0.02 |